Skip to content

TransMedics Group, Inc. TMDX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$171.92M+251%$190.29M+437%$91.77M$71.66M$48.95M
$32.91M+52.4%$27.19M+37.6%$25.4M+43.6%$23.73M+64.8%$21.59M+92.9%
$37.86M+7.2%$36.86M+10.9%$38.23M+35.7%$37.04M+45.7%$35.31M+55.3%
$220.23M+346%$192.84M+295%$177.99M$115.27M$49.38M
$68.87M-38.8%$59.25M-54.3%$57.34M-63.7%$97.92M-55.0%$112.61M-42.3%
-$68.87M+38.6%-$59.25M+54.2%-$57.34M+63.6%-$97.48M+62.4%-$112.17M+52.7%
$17.59M-22.6%$16.86M-26.3%$14.94M-33.9%$19.17M+17.8%$22.72M-94.3%
$169.53M$151.72M
$151.36M$133.59M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does TransMedics Group, Inc. generate?
TransMedics Group, Inc. (TMDX) generated $220.2M in operating cash flow over the trailing twelve months.
What is TransMedics Group, Inc.'s free cash flow?
After $68.9M of capital expenditures, TransMedics Group, Inc.'s free cash flow was $151.4M over the trailing twelve months, up 199.3% year over year.
Where does TransMedics Group, Inc.'s cash flow data come from?
Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.